Banna GL, Cantale O, Friedlaender A, Yusof H, Acharige S, Addeo A.
Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immunotherapy alone or in combination with chemotherapy
Cancer Invest - 2021; Cancer Invest 2021 Aug 19;1-12.
Rundo F, Bersanelli M, Urzia V, Friedlaender A, Cantale O, Calcara G, Addeo A, Banna GL.
Three-Dimensional deep noninvasive radiomics for the prediction of disease control in patients with metastatic urothelial carcinoma treated with immunotherapy
Clinical Genitourinary Cancer - 2021; Clin Genitourin Cancer 2021 Mar 19; S1558-7673
Blanco G., Longo C., Leotta E., Caltavuturo C., Puglisi C., Giuffrida P., Vitale M.L., Prestifilippo A., Puliafito I., Giuffrida D.
Cetuximab Use in Laryngeal Squamous Cells Carcinoma: A 4-Years Follow-up Case Report
Clinics in Oncology - 2021; Volume 6: 1781
Gagliano A, Prestifilippo A, Cantale O, Ferini G, Fisichella G, Fontana P, Sciacca D, Giuffrida D.
Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice
Frontiers in Oncology - 2021; Front Oncol
. 2021 Jun 17;11:643155.
Broggi G, Lo Giudice A, Di Mauro M, Asmundo MG, Pricoco E, Piombino E, Calatabiano R, Morgia G, Russo GI.
SRSF-1 and microvessel density immunohistochemical analysis by semi-automated tissue microarray in prostate cancer patients with diabetes (DIAMOND study)